Related Articles
Pfizer scraps $160 billion merger with Allergan
NEW YORK (TIP): US pharmaceutical giant Pfizer said Wednesday it was abandoning plans for a $160 billion merger with Allergan, citing new US rules cracking down on tie ups aimed at saving on taxes. The […]
Be the first to comment